PedAM
Pediatric Disease Annotations & Medicines
| Disease | vascular disease |
| Symptom | |diabetes |
| Sentences | 526 |
| PubMedID- 24595856 | Aims/hypothesis: obesity and diabetes increase the risk of developing cardiovascular diseases and heart failure. |
| PubMedID- 24977070 | Patients were excluded for the following reasons: age over 75 or under 55, previous surgery to the index joint, inflammatory arthritis, relevant comorbidity (tumors, diabetes mellitus, history of respiratory disease, cardiovascular disease, mental health problems, musculoskeletal system diseases, previous endocrinological diagnosis) or refusal to answer to the questionnaires. |
| PubMedID- 22994940 | Our empirical strategy starts with a basic model construct (model 1) that uses control variables such as age, sex, previously diagnosed disease, and health problems (diabetes mellitus, risk of vascular disease, vascular disease, musculoskeletal disease, digestive disease, mental illness, other diseases, and report of an accident in the last 12 months). |
| PubMedID- 26383851 | in taiwan, where they found a higher prevalence of vascular diseases associated with diabetes in females than in males. |
| PubMedID- 25629920 | A descriptive, cross-sectional survey was undertaken in 1800 individuals without diabetes or a history of cardiovascular disease (cvd). |
| PubMedID- 25913343 | The miami healthy heart initiative is a randomized control trial designed to examine the effectiveness of chws on reducing the risk for cardiovascular disease among hispanics with poorly controlled diabetes in south florida. |
| PubMedID- 20877687 | Endothelial dysfunction is a major contributor to the pathogenesis of vascular disease in diabetes mellitus patients and has recently received increased attention. |
| PubMedID- 23751310 | Metformin, the first-line medication for diabetes, has the superiority of reducing risk of macrovascular diseases, all-cause mortality and even possibly cancers. |
| PubMedID- 22115901 | Observational studies suggest an association between the extent of hyperglycaemia and the risk of death and of macrovascular and microvascular disease in patients with type 2 diabetes.1 2 3 three recent randomised clinical trials in patients with type 2 diabetes were not able to detect (or reject the possibility of) reduced cardiovascular disease or mortality with intensive compared with conventional glycaemic control.4 5 6 worries arose as the results from the action to control cardiovascular risk in diabetes (accord) trial in 2008 showed increased all cause mortality and cardiovascular mortality in the intensive treatment group compared with conventional treatment.4 the increased mortality led to early termination of the accord trial.4 on the other hand, randomised clinical trials have indicated a beneficial effect on microvascular complications of intensive versus conventional glycaemic control in patients with type 2 diabetes. |
| PubMedID- 21256163 | Cardiovascular disease is common in patients with diabetes and is a significant contributor to the high mortality rates associated with diabetes. |
| PubMedID- 26202844 | Postprandial bgls have been shown to increase the risk factors for cardiovascular disease in people with type 1 diabetes . |
| PubMedID- 23451184 | To date, growing clinical evidence indicates that nafld is linked to an increased risk of cardiovascular disease (cvd) both in patients without diabetes and in those with type 2 diabetes . |
| PubMedID- 23798924 | positive results in different clinical trials have strengthen the value and acceptance of hscrp, which is recommended as a predictive laboratory marker for cardiovascular disease risk in patients with diabetes mellitus. |
| PubMedID- 25658588 | Abbreviations: bmi, body mass index; egfr, estimated glomerular filtration rate; proteinuria, proteinuria positive; dm, diabetes mellitus; cvd, history of cardiovascular disease; hyperuricemia, history of hyperuricemia including gout; alcohol, daily alcohol consumption; exercise, having regular exercise. |
| PubMedID- 26178521 | Obesity is a well-known risk factor for several chronic illnesses including type ii diabetes, hypertension and scores of cardiovascular diseases. |
| PubMedID- 24023876 | Activity causing sweating and/or breathlessness), current daily smoking (cigarettes/cigar/pipe), self-reported diabetes and history of cardiovascular disease cvd (angina pectoris, myocardial infarction or stroke) were obtained from the questionnaires. |
| PubMedID- 21749443 | Aims: to assess the effect of various measures of adiposity and of metabolic risk factors, both separately and in combination, on the risk of future type 2 diabetes in patients with manifest vascular diseases. |
| PubMedID- 23050905 | Half of all deaths from diabetes are due to cardiovascular disease and stroke. |
| PubMedID- 25251664 | Patient empowerment programme in primary care reduced all-cause mortality and cardiovascular diseases in patients with type 2 diabetes mellitus: a population-based propensity-matched cohort study. |
| PubMedID- 23217598 | Prevalence of hypertension and dyslipidemia and their associations with micro- and macrovascular diseases in patients with diabetes in taiwan: an analysis of nationwide data for 2000-2009. |
| PubMedID- 22952467 | Cardiovascular disease in patients with diabetes mellitus remains one of the leading causes of morbidity and mortality. |
| PubMedID- 21525440 | Hypertension is a leading risk factor for mortality in both developing and developed countries (1) and a well established risk factor for cardiovascular disease (cvd) in patients with diabetes (2). |
| PubMedID- 25279360 | Introduction: diabetes mellitus is associated with cardiovascular disease. |
| PubMedID- 24259900 | Type 2 diabetes belongsto a group of diseases (cardiovascular diseases, alzheimer's disease, cancer, etc.) |
| PubMedID- 25554536 | Effect of statin therapy on incident type 2 diabetes mellitus in patients with clinically manifest vascular disease. |
| PubMedID- 20609967 | Conversely, any preferential diagnosis of vascular disease in people with diabetes would have tended to overestimate hrs. |
| PubMedID- 24187621 | Risk of cardiovascular diseases in diabetes mellitus and serum concentration of asymmetrical dimethylarginine. |
| PubMedID- 21318583 | The underlying causes for this disconnect are not known, but may be related to species differences, bleeding time versus spontaneous bleeding, vascular bed differences, and the fact that unlike animal bleeding models, the appraise-2 patients had the highest tendency to bleed due to advanced age, diabetes, complications of cardiovascular disease, other comorbidities and the additive hazards of combination antiplatelet treatment. |
| PubMedID- 20622162 | It certainly may be that this rapid aging of apoa-1, a key protein in lipoprotein metabolism, causes the known higher risk for macrovascular disease in people with type 1 diabetes (20). |
| PubMedID- 20647285 | In this study, intensive nutrition treatment achieved an improvement in both glycaemic control and anthropometric measures in patients with type 2 diabetes at high risk of cardiovascular disease whose control was considered to be unsatisfactory despite optimum drug treatment according to international management guidelines.17 18 19 this effect occurred despite the fact that some of the patients considered to be on maximum drug treatment were able to reduce their dose of tablets or insulin. |
| PubMedID- 22985021 | Aim: to examine how diabetes in combination with cardiovascular diseases (hypertension, heart disease and stroke) and geriatric conditions (cognitive impairment and depressive symptoms) affects the odds of disability in older adults. |
| PubMedID- 23841986 | Patients with diabetes are at risk of macrovascular and microvascular disease . |
| PubMedID- 24688225 | In t2dm smoking cigarettes may protect against the progression of retinopathy in some patients, despite the fact that it is an independent risk factor for myocardial infarction and death from cardiovascular disease in patients with diabetes . |
| PubMedID- 25995772 | In addition, oxldl is an important factor for predicting cardiovascular disease in patients with diabetes . |
| PubMedID- 23144974 | In univariate analysis, age, diabetes mellitus, previous history of cardiovascular disease, smoking, lipid-lowering therapy, serum albumin, ipth, and hs-crp concentrations were significantly associated with the presence of aoac at baseline. |
| PubMedID- 25878764 | It is also associated with severe complications; for example, diabetes doubles the risk of developing cardiovascular diseases (cvd) that currently constitute the leading cause of mortality in developed countries 2. |
| PubMedID- 24255692 | Atorvastatin use may also result in the primary prevention of cardiovascular disease in patients with type ii diabetes (3). |
| PubMedID- 23718574 | Cardiovascular diseases in patients with type 2 diabetes are a large and increasing health problem. |
| PubMedID- 26353872 | Risk factors included age, body mass index (bmi), systolic blood pressure, cholesterol/ high-density lipoprotein (hdl) ratio, glycosylated haemoglobin (hba1c), material deprivation, ethnicity, smoking, diabetes duration, type of diabetes, atrial fibrillation, cardiovascular disease, chronic renal disease, and family history of premature coronary heart disease. |
| PubMedID- 22682738 | Mortality in diabetes compared with previous cardiovascular disease: a gender-specific meta-analysis. |
| PubMedID- 23755276 | Chronic hyperglycemia in diabetes is associated with cardiovascular disease and microvascular pathologies in the retina, kidney and peripheral nerves . |
| PubMedID- 24843558 | Hazard ratios for cardiovascular disease in patients with diabetes classified according to (a) the standard deviation (sd) and mean hba1c and (b) the coefficient of variation (cv) and mean of hba1c during the follow‐up period. |
| PubMedID- 26175995 | Postprandial hyperglycemia performs the important function in the development of type 2 diabetes and complications associated with cardiovascular diseases. |
| PubMedID- 24465187 | Hrs were adjusted for cohort as a random effect and for sex, age, body mass index, smoking, total cholesterol, diabetes mellitus, and history of cardiovascular disease as fixed effects. |
| PubMedID- 25621136 | The combination therapy of ppar-α and ppar-γ agonists led to a decrease in ldl-c levels, and might be of benefit in the treatment of type 2 diabetes patients with cardiovascular disease by downregulating cytokines37. |
| PubMedID- 23349538 | This has implications for atherogenesis and vascular disease in diabetes and insulin-resistant states. |
| PubMedID- 23742753 | The final risk score consisted of eight variables and a potential total score of 10. points were assigned as follows: two for recent hospitalization or icu admission; one each for age < 30 or > 79 years, prior iv antibiotic exposure, dementia, cerebrovascular disease, female with diabetes, or recent exposure to a nursing home/long term acute care facility/skilled nursing facility. |
| PubMedID- 24172142 | Furthermore, there was a strong increase in the proportion of patients between 40 and 70 years suffering from cardiovascular diseases in combination with hyperlipidemia and/or diabetes mellitus. |
| PubMedID- 23564913 | In previous studies, statin therapy has been associated with a 19–55% reduction in cardiovascular disease events in patients with diabetes (33). |
| PubMedID- 23625211 | In part ii of this review, we describe the epidemiology and clinical consequences of vascular disease in patients with diabetes, and discuss the efficacy of risk factor modification and antiplatelet treatment. |